Ravi Kiran Kaja

Ravi Kiran Kaja is a prominent scientific leader in the pharmaceutical industry, currently serving as Senior Principal Scientist in Complex Generics at US Pharmacopeia since March 2023, where responsibilities include shaping public quality standards and fostering innovation in regulatory science and public health. Previously, Ravi held key positions at DAICEL Chiral Technologies India Private Limited, leading analytical R&D and project management, and at Alembic Pharmaceuticals Limited, overseeing formulation analytical development for oncology and non-oncology injectables. Additionally, Ravi contributed to Pfizer's Global Technical Services team as Chief Research Scientist, enhancing analytical excellence and facilitating tech transfers. Starting career at USP-India Private Limited as a Senior Scientist-I, Ravi supported global pharmacopeial standards and regulatory initiatives. Educational credentials include a Ph.D. in Analytical Chemistry from Acharya Nagarjuna University and an M.Phil. from Alagappa University.